Acorda Therapeutics
Acorda Therapeutics develops therapies to improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders. It manufactures and markets Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the US. Its ARCUS technology transforms medicines into light, respirable dry powders.
Headquaters
Acorda Therapeutics, Inc
2 Blue Hill Plaza, 3rd Floor
Pearl River
NY 10965
United States
Acorda Therapeutics is a biotechnology company that develops therapies to improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders. The company manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the US. Its ARCUS technology platform transforms medicines into light, respirable dry powders.
Authors and Contacts
Article
